Search Results
Dr. Snyder on How Ruxolitinib and Fedratinib May Pave the Way to Transplant in Myelofibrosis
Dr. Kuykendall on Toxicity Profiles of Ruxolitinib and Fedratinib in Myelofibrosis
Dr. Mesa on the Utility of Ruxolitinib Versus Fedratinib in Myelofibrosis
Dr. Saint Fleur-Lominy on the Use of Ruxolitinib Versus Fedratinib in MPNs
Dr. Rossetti on the Utility of JAK Inhibitors in MPNs
6th Annual Canadian MPN Patient Conference - Part 2
